PhenMol disentangles molecular and cellular representations into shared and private components, enabling phenotype-guided alignment while preserving chemical structures through a dedicated molecular branch, and improves molecular property prediction across 270 bioactivity tasks, molecule--phenotype retrieval, and clinical trial outcome prediction.
Abstract
Phenotypic drug discovery enables the discovery of functional relationships between molecular structures and cellular responses. However, existing multimodal representation learning methods often optimize cross-modal alignment without considering the intrinsic organization of chemical space, resulting in distorted molecular representations and loss of structural information. We propose \textbf{PhenMol}, a structure-preserving framework for phenotype-aware molecular representation learning. PhenMol disentangles molecular and cellular representations into shared and private components, enabling phenotype-guided alignment while preserving chemical structures through a dedicated molecular branch. This design integrates cellular phenotype information without disrupting molecular neighborhood organization. Experiments on approximately $3.04 \times 10^{4}$ molecule--cell morphology pairs demonstrate that PhenMol improves molecular property prediction across 270 bioactivity tasks, molecule--phenotype retrieval, and clinical trial outcome prediction. Moreover, ECFP4-based structural analysis shows that PhenMol better preserves molecular neighborhoods and reduces embedding distortion compared with existing multimodal alignment methods. These results highlight the importance of structure-aware constraints in multimodal molecular representation learning and provide an effective approach for integrating cellular phenotypes with chemical knowledge for drug discovery.
A two-stage contrastive learning framework integrating drug structures, protein sequences, and Cell Painting morphological profiles into a unified embedding space, which reveals pathway-specific morphological signatures associated with drug targets, providing biologically interpretable insights into drug mechanisms.
This review provides a systematic overview of recent advances in SSL-based molecular property prediction and analyzes how multimodal molecular representation learning by integrating sequence, graph, three-dimensional structure, and textual information can improve the quality and expressiveness of molecular representati...
Shuning Yang, Lei Deng· Journal of Chemical Informat...· 0 citations
The results establish NOT as a promising framework for predicting cellular phenotypes from molecular structure and negative-control phenotypes, while highlighting the development of more informative molecular representations as a key direction for improving out-of-distribution performance.
Gauthier Avité, Maxime Sanchez-Renauld, Nicolas Bourriez et al.· 0 citations
PMRD separates mechanism-consistent factors from modality-specific information and constructs a consensus response domain across three modalities and combines complementary representations through reliability-aware multiview retrieval and supports PMRD as an effective framework for mechanism-aware multimodal drug repre...
Jintao Huang, Lu Leng, Ziyuan Yang· arXiv.org· 0 citations
It is suggested that incorporating bioactivity similarity during pretraining can enrich molecular representations and improve drug-drug interaction prediction and exhibit enhanced sensitivity in distinguishing structurally similar molecules with subtle chemical differences.
Yan-Peng Zhao, Guowei Zhou, Jingjing Wang et al.· Molecular diversity· 0 citations
MG-CMIF is developed, a multi-granularity cross-modal framework for molecular property prediction that achieves better prediction results than competitive methods in both classification and regression settings and confirms that hierarchical structural modeling and cross-view integration both contribute to the effective...
Qun Liu, Mao-Yuan Zang, Rui Han et al.· Journal of Machine Learning...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.